EU regulator backs new Alzheimer’s drug, months after rejecting it
An expert committee recommended that the drug be offered to a narrow group of patients with early-stage Alzheimer’s disease.
شرح الذكاء الاصطناعي
Expert committee recommends drug for narrow group of early-stage Alzheimer's patients
